Randomized study of vinorelbine–gemcitabine versus vinorelbine–carboplatin in patients with advanced non-small cell lung cancer
- 31 August 2005
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 49 (2), 233-240
- https://doi.org/10.1016/j.lungcan.2005.03.029
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003Journal of Clinical Oncology, 2004
- Platin or No Platin? That Is the QuestionJournal of Clinical Oncology, 2003
- Gemcitabine Plus Vinorelbine Compared With Cisplatin Plus Vinorelbine or Cisplatin Plus Gemcitabine for Advanced Non–Small-Cell Lung Cancer: A Phase III Trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials GroupJournal of Clinical Oncology, 2003
- Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinomaCancer, 2002
- Carboplatin and vinorelbine in untreated locally advanced and metastatic non-small cell lung cancerLung Cancer, 2001
- Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trialThe Lancet, 2001
- Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer: a phase II trialEuropean Journal Of Cancer, 2001
- Gemcitabine and vinorelbine in advanced nonsmall cell lung carcinomaCancer, 2000
- 1089: Chemotherapy with vlnorelblne (navelbine: NVB) + carboplatin in advanced non-small cell lung cancer (NSCLC)European Journal Of Cancer, 1997
- A Dose-Escalating Study of Carboplatin Combined with Vinorelbine in Non-Small-Cell Lung CancerOncology, 1996